Finasteride en es it fr

Finasteride Brand names, Finasteride Analogs

Finasteride Brand Names Mixture

  • No information avaliable

Finasteride Chemical_Formula


Finasteride RX_link

Finasteride fda sheet

Finasteride FDA

Finasteride msds (material safety sheet)

Finasteride Synthesis Reference

No information avaliable

Finasteride Molecular Weight

372.544 g/mol

Finasteride Melting Point

252-254 oC

Finasteride H2O Solubility

11.7 mg/L

Finasteride State


Finasteride LogP


Finasteride Dosage Forms


Finasteride Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostat.

Finasteride Pharmacology

Finasteride is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only. Finasteride is a competitive and specific inhibitor of Type II 5a-reductase, an intracellular enzyme that converts the androgen testosterone into DHT. Two distinct isozymes are found in mice, rats, monkeys, and humans: Type I and II. Each of these isozymes is differentially expressed in tissues and developmental stages. In humans, Type I 5a-reductase is predominant in the sebaceous glands of most regions of skin, including scalp, and liver. Type I 5a-reductase is responsible for approximately one-third of circulating DHT. The Type II 5a-reductase isozyme is primarily found in prostate, seminal vesicles, epididymides, and hair follicles as well as liver, and is responsible for two-thirds of circulating DHT.

Finasteride Absorption

No information avaliable

Finasteride side effects and Toxicity

No information avaliable

Finasteride Patient Information

No information avaliable

Finasteride Organisms Affected

Humans and other mammals